» Articles » PMID: 20947763

Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation

Overview
Journal Science
Specialty Science
Date 2010 Oct 16
PMID 20947763
Citations 614
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils are recruited from the blood to sites of sterile inflammation, where they contribute to wound healing but may also cause tissue damage. By using spinning disk confocal intravital microscopy, we examined the kinetics and molecular mechanisms of neutrophil recruitment to sites of focal hepatic necrosis in vivo. Adenosine triphosphate released from necrotic cells activated the Nlrp3 inflammasome to generate an inflammatory microenvironment that alerted circulating neutrophils to adhere within liver sinusoids. Subsequently, generation of an intravascular chemokine gradient directed neutrophil migration through healthy tissue toward foci of damage. Lastly, formyl-peptide signals released from necrotic cells guided neutrophils through nonperfused sinusoids into the injury. Thus, dynamic in vivo imaging revealed a multistep hierarchy of directional cues that guide neutrophil localization to sites of sterile inflammation.

Citing Articles

FPR1 affects acute rejection in kidney transplantation by regulating iron metabolism in neutrophils.

Li P, Ji W, Zhang B, Jia H, Wang J, Sun Z Mol Med. 2025; 31(1):23.

PMID: 39849390 PMC: 11758745. DOI: 10.1186/s10020-025-01077-w.


Deciphering the Complexity of the Immune Cell Landscape in Kidney Allograft Rejection.

Terinte-Balcan G, Lebraud E, Zuber J, Anglicheau D, Ismail G, Rabant M Transpl Int. 2024; 37:13835.

PMID: 39722854 PMC: 11668586. DOI: 10.3389/ti.2024.13835.


Blocking CCL3-mediated neutrophil recruitment into the brain alleviates immunopathology following severe enterovirus 71 infection.

Yang W, Li L, Li G, Li X, Liu H, Han X iScience. 2024; 27(12):111388.

PMID: 39660056 PMC: 11629326. DOI: 10.1016/j.isci.2024.111388.


Neutrophils in cancer: from biology to therapy.

Koenderman L, Vrisekoop N Cell Mol Immunol. 2024; 22(1):4-23.

PMID: 39653768 PMC: 11686117. DOI: 10.1038/s41423-024-01244-9.


Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment.

Cao Z, Tian K, Ran Y, Zhou H, Zhou L, Ding Y Front Immunol. 2024; 15:1506426.

PMID: 39650649 PMC: 11621085. DOI: 10.3389/fimmu.2024.1506426.